Finnish Lung Cancer Group
1 clinical trials · Sponsor
◉ Watch Finnish Lung Cancer Group
| Record | Firm | Date |
|---|---|---|
| Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC (NCT02064491) | Finnish Lung Cancer Group | 2014-02-01 |
Track Finnish Lung Cancer Group automatically
Every clearance here is in the API, with alerts when new ones post.